We are live on
!
Find out more
PCM
Princeton Capital Management Portfolio holdings
AUM
$367M
1-Year Est. Return
45.24%
This Fund
S&P 500
This Quarter
Est. Return
-17%
1 Year Est. Return
+45.24%
3 Year Est. Return
+147.52%
5 Year Est. Return
+173.99%
10 Year Est. Return
–
AUM
$258M
AUM Growth
-$64M
(-20%)
Cap. Flow
-$2.75M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
48.58%
Holding
112
New
2
Increased
35
Reduced
43
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.02M |
| 2 |
Apple
AAPL
|
+$413K |
| 3 |
iShares S&P GSCI Commodity-Indexed Trust
GSG
|
+$346K |
| 4 |
iShares US Basic Materials ETF
IYM
|
+$302K |
| 5 |
JPMorgan Chase
JPM
|
+$265K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.31M |
| 2 |
FARO
Faro Technologies
FARO
|
+$1.1M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$517K |
| 4 |
Invesco QQQ Trust
QQQ
|
+$516K |
| 5 |
Qorvo
QRVO
|
+$421K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.14% |
| 2 | Healthcare | 16.23% |
| 3 | Communication Services | 14.43% |
| 4 | Real Estate | 10.21% |
| 5 | Industrials | 9.82% |
Similar funds
CAM
LP
NWM
V
RAM
AA
MWPCG
BA
Princeton Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Princeton Capital Management held 112 positions worth $258M, down 20% from $322M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Princeton Capital Management's Q2 2022 filing shows 2 new, 35 increased, 43 reduced and 16 closed positions. Its largest new stake was iShares S&P GSCI Commodity-Indexed Trust: 14,314 shares worth $331K. The largest sale was Bristol-Myers Squibb, an estimated $1.31M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 37% a quarter earlier, followed by Healthcare and Communication Services.
- Princeton Capital Management's largest Q2 2022 buy was iShares S&P GSCI Commodity-Indexed Trust: 14,314 shares worth $331K.
- Princeton Capital Management added most to Eli Lilly in Q2 2022, an estimated $2.02M increase.
- Princeton Capital Management's biggest Q2 2022 reduction was Bristol-Myers Squibb, cutting an estimated $1.31M.
- Princeton Capital Management fully exited Faro Technologies in Q2 2022, selling an estimated $1.1M.
- Princeton Capital Management's ten largest holdings make up 49% of its $258M portfolio in Q2 2022.
- Princeton Capital Management opened 2 new positions and closed 16 in Q2 2022.
- Princeton Capital Management's portfolio value fell 20% quarter-over-quarter to $258M.
Based on Princeton Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.